AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metfotia-G2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Querencia Healthcare Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Metfotia-G2 Tablet SR

Diabex Duo SR tablets are a dual-action antidiabetic medication, combining two components to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (rapid-acting glucose source like sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Individuals with a history of heart disease should inform their doctor before starting Diabex Duo SR. Pregnant or breastfeeding women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Uses of Metfotia-G2 Tablet SR

Managing type 2 diabetes

Major Benefits of Metfotia-G2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metfotia-G2 Tablet SR should be administered with a meal.

Common Side effects of Metfotia-G2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metfotia-G2 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metfotia-G2 Tablet SR should be administered with a meal.

How Metfotia-G2 Tablet SR works:

Glimepiride and Metformin, the components of Metfotia-G2 SR tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose uptake, and enhancing the body's responsiveness to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metfotia-G2 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Metfotia-G2 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Metfotia-G2 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Metfotia-G2 Tablet SR, potentially requiring dosage modification under medical supervision. Metfotia-G2 Tablet SR is contraindicated in individuals with severely compromised kidney function. Routine monitoring of renal parameters is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metfotia-G2 SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Low initial doses are typically prescribed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Metfotia-G2 Tablet SR :

Should you forget a dose of Metfotia-G2 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metfotia-G2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metfotia-G2 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metfotia-G2 Tablet SR can cause lactic acidosis, a serious medical emergency (also known as MALA – Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. While rare, this harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Metfotia-G2 Tablet SR and seek immediate medical attention.
Metfotia-G2 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Metfotia-G2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metfotia-G2 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metfotia-G2 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metfotia-G2 Tablet SR and alcohol is unsafe. Alcohol can intensify Metfotia-G2's blood sugar-lowering effect, risking hypoglycemia and increasing the likelihood of lactic acidosis.
Metfotia-G2 Tablet SR
45
MRP 55
18% off